Spotlight Stock Market

Market Notice 130/26 – Information regarding the rights issue from Double Bond Pharmaceutical International AB

Källa: Cision
Neutral

The last day of trading in the company’s shares, DBP B, including the right to receive subscription rights is November 12, 2026. The first day excluding the right to obtain the rights is November 13, 2026.

One (1) share entitles the owner to one (1) subscription right. Twelve (12) subscription rights entitle the owner to subscribe for five (5) new shares, at the price of SEK 0,11 (5:12 á 0,11 SEK).

The subscription period lasts from November 18, 2026, to December 2, 2026.

Information about the subscription right:  Short name: DBP TR B ISIN-code: SE0031088687 Orderbook-ID: 567508 CFI: RSSXXR FISN: DOUBLEBOND/SUBS RTS NL PD First day of trading: November 18, 2026 Last day of trading: November 27, 2026 Market Segment: SPSE MIC Code: XSAT Tick size: 2 

Information about the paid subscribed share: Shortname: DBP BTA B ISIN-code: SE0031088695 Orderbook-ID: 567509 CFI: ESNUFR FISN: DOUBLEBOND/SH B Trading period: November 18, 2026, until the registration of the issue at Bolagsverket. Market Segment: SPSE MIC Code:  XSAT Tick size: 2  

Please be advised that if the rights issue give rise to a conversion factor, all overnight orders in the company’s order book will be flushed. If so, this will occur after closing on November 12, 2026.

Stockholm November 10, 2026

Spotlight Stock Market 08-511 68 000  backoffice@spotlightstockmarket.com